S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Anti-Tumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells

By
Bob
-
0
143
Investigators developed a novel humanized anti-CCR8 monoclonal antibody, S-531011, aimed as a cancer immunotherapy strategy for patients with cancer.
[Molecular Cancer Therapeutics]
Abstract